C9orf72 and the Care of the Patient With ALS or FTD
Progress and Recommendations After 10 Years
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received July 25, 2020
- Accepted in final form October 19, 2020
- First Published December 21, 2020.
Author Disclosures
- Jennifer Roggenbuck, MS, CGC
- Jennifer Roggenbuck, MS, CGC
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
I receive research support from the Packard Foundation.
NONE
NONE
NONE
NONE
NONE
NONE
- From the Departments of Neurology and Internal Medicine, The Ohio State University Wexner Medical Center, Columbus.
- Correspondence
J. Roggenbuck jennifer.roggenbuck{at}osumc.edu
Article usage
Cited By...
Letters: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Jeffrey Allen and Dr. Nicholas Purcell
► Watch
Related Articles
- No related articles found.
Topics Discussed
Alert Me
Recommended articles
-
Article
Screening for novel hexanucleotide repeat expansions at ALS- and FTD-associated lociFang He, Julie M. Jones, Claudia Figueroa-Romero et al.Neurology Genetics, May 11, 2016 -
Articles
Hexanucleotide repeat expansions in C9ORF72 in the spectrum of motor neuron diseasesWouter van Rheenen, Marka van Blitterswijk, Mark H.B. Huisman et al.Neurology, July 25, 2012 -
Article
Amyotrophic Lateral Sclerosis Genetic Access ProgramPaving the Way for Genetic Characterization of ALS in the ClinicJennifer Roggenbuck, Kelly A. Rich, Leah Vicini et al.Neurology: Genetics, August 10, 2021 -
Article
Somatic expansion of the C9orf72 hexanucleotide repeat does not occur in ALS spinal cord tissuesJay P. Ross, Claire S. Leblond, Hélène Catoire et al.Neurology: Genetics, March 20, 2019